Huisheng Oral Solution Adjunct With Platinum-Based Chemotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review

• Päätekijät: Jingyi Huang (Tekijä), Zhichao Wang (Tekijä), Han Xue (Tekijä), Ailing Cao (Tekijä), Cassidy Turner (Tekijä), Jing Wang (Tekijä), Li Zhang (Tekijä), Jinghai Wang (Tekijä), Na Xiao (Tekijä), Jie Xu (Tekijä), Xianmei Zhou (Tekijä), Hailang He (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2020-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

BackgroundPlatinum-based chemotherapy is one of the first line therapies for the advanced non-small cell lung cancer (NSCLC), even though its high toxicity and limited clinical effects cannot be neglected. Huisheng oral solution (HSOS) has been widely used as an adjuvant chemotherapy drug for NSCLC...